Drug Helps Reprogram Macrophage Immune Cells, Supp

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to r

Related Keywords

Maryland ,United States ,Johns Hopkins University ,American ,Monali Praharaj ,Robertd Leone ,Alokk Singh ,Roberte Meyerhoff ,Edwardj Pearce ,Raekwona Williams ,Jelani Zarif ,Thomasr Nirschl ,Johns Hopkins ,Lauraa Sena ,Ada Tam Srinivasan Yegnasubramanian ,Karaa Lombardo ,Barbara Slusher ,Alexj Lee ,Liang Zhao ,Kennethm Adusei ,Debebe Theodros ,Jonathan Powell ,Elizabetha Thompson ,Xiaoxu Wang ,Maryland Cigarette Restitution Fund ,National Institutes Of Health Cancer Institute ,Bloomberg ,Prostate Cancer Foundation Young Investigator Award ,Kimmel Institute For Cancer Immunotherapy ,Johns Hopkins Kimmel Cancer Center ,Dracen Pharmaceuticals ,American Association For Cancer Research ,Cancer Immunology Research ,Bloomberg Kimmel Institute For Cancer Immunotherapy ,Kimmel Institute ,Johns Hopkins Drug ,American Association ,Endowed Professor ,Johns Hopkins Drug Discovery ,Yifan Shen ,Ada Tam ,Srinivasan Yegnasubramanian ,Jesse Alt ,Rana Rais ,National Institutes ,National Cancer Institute ,